Medifast (FRA:MDF) 50-Day SMA: €9.77 (As of Jul. 02, 2026)


FRA:MDF Medifast Inc FRA:MDF
68 GF Score
Price €9.08
GF Value €7.15
Valuation Modestly Overvalued
! 2 Warning Signs
View Full Analysis

What is Medifast 50-Day SMA?

Medifast FRA:MDF -1.73% 68 50-Day SMA is €9.77 as of Jul. 02, 2026. GuruFocus rates FRA:MDF with a GF Score™ of 68/100 and a GF Value™ of €7.15 (Modestly Overvalued). The stock has 2 warning signs investors should review.

Moving averages are one of the core indicators in technical analysis. A Simple Moving Average (SMA) is simply the arithmetic average of stock price over a period. It is calculated by adding a selected range of prices, usually closing prices, and then dividing that figure by the number of time periods in that range.

The 50-Day SMA calculates the average price over 50 days. And the 20-Day SMA and 200-Day SMA calculates the average price over 20 days and 200 days separately.

As of today (2026-07-02), Medifast's 50-Day SMA is €9.77. It's 20-Day SMA is €9.55 and 200-Day SMA is €9.33.


Medifast  (FRA:MDF) 50-Day SMA Explanation

Simple Moving Average (SMA) is the arithmetic average of stock price over a period. The 20-Day SMA calculates the average price over 20 days. And the 50-Day SMA and 200-Day SMA calculates the average price over 50 days and 200 days separately. SMAs are often used to determine the price trend direction. A 200-Day SMA is usually a proxy for the long-term trend, while shorter periods indicate short-term trend.

SMA are commonly compared with stock price or different period SMAs to indicate a trading signal. Generally speaking, if the price goes above the SMA, or a short-term SMA crosses above a long-term SMA, an uptrend is expected, investors may want to go long or cover short. Conversely, if the price goes below the SMA, or the short-term SMA crosses below a long-term SMA, a downtrend is expected, investors may want to go short or exit long.

Two popular trading patterns that use SMA include the death cross and a golden cross. A death cross occurs when the 50-day SMA crosses below the 200-day SMA. This is considered a bearish signal, that further losses are in store. The golden cross is a bullish signal which occurs when a short-term SMA crosses above a long-term SMA.


Medifast 50-Day SMA Related Terms


FRA:MDF vs RGS, EVTK, DROR: 50-Day SMA Comparison

For the Personal Services subindustry, Medifast's 50-Day SMA, along with its competitors' market caps and 50-Day SMA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medifast 50-Day SMA vs Personal Services Industry

For the Personal Services industry and Consumer Cyclical sector, Medifast's 50-Day SMA distribution charts can be found below:

* The bar in red indicates where Medifast's 50-Day SMA falls into.


FRA:MDF
68GF Score
Medifast Inc FRA:MDF
50-Day SMA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medifast  (FRA:MDF) 50-Day SMA Calculation

The formula for calculating SMA is:

SMA=( P1 + P2 + ... + Pn ) / n

where:
Pn is the price of the stock at period n.
n is the total number of periods.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 50-Day SMA →
What does a 50-Day SMA of €9.77 mean?
Medifast (FRA:MDF) has a 50-Day SMA of €9.77 as of Jul. 02, 2026. Simple Moving Average (SMA) is the arithmetic average of stock price over a period. View historical data on Medifast and its competitors.
Is Medifast's 50-Day SMA too high?
Medifast's current 50-Day SMA is €9.77. Overall, Medifast has a GF Score™ of 68/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medifast's 50-Day SMA compare to RGS and EVTK?
Medifast's 50-Day SMA of €9.77 can be compared against companies in the Personal Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 50-Day SMA for a Personal Services company?
A good 50-Day SMA depends on the Personal Services industry context. However, 50-Day SMA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 50-Day SMA mean?
A high 50-Day SMA can signal that a stock is expensive relative to its fundamentals. Simple Moving Average (SMA) is the arithmetic average of stock price over a period. View historical data on Medifast and its competitors. Medifast's current 50-Day SMA is €9.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medifast stock overvalued right now?
Based on GuruFocus' analysis, Medifast (FRA:MDF) is currently considered Modestly Overvalued. The stock's GF Value™ is €7.15, compared to a current price of €9.08 — trading 27% above its estimated fair value. The current 50-Day SMA is €9.77. Medifast's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 50-Day SMA calculated?
50-Day SMA is calculated from a company's financial statements. For Medifast (FRA:MDF), the current 50-Day SMA is €9.77 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medifast (FRA:MDF) Overvalued in 2026?

Based on GuruFocus' analysis, Medifast stock appears to be overvalued. The current stock price of €9.08 is trading 27% above its estimated GF Value™ of €7.15. GuruFocus considers Medifast to be Modestly Overvalued.

Key valuation signals for FRA:MDF:

  • 50-Day SMA: €9.77
  • GF Value™: €7.15 vs. price of €9.08 (27% above fair value)
  • GF Score™: 68/100 with 2 warning signs

No single metric tells the full story. See the FRA:MDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medifast Business Description

Other Exchanges MED:USA0K05:UKMDF:Germany
Address 100 International Drive, Baltimore, MD, USA, 21202
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
68GF Score

Get the complete analysis for FRA:MDF

50-Day SMA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.08
Price
€7.15
GF Value